(In thousands, except per-share amounts)

Company Symbol/ Revenues / Profits Per share R & D Cash Shares Period % change Current/comp Current/comp % Change or Equiv.Alpha 1 Biomedicals ALBM/1Q 34/-92% (2,800)/(1,016) (0.31)/(0.13) NA/NA NA 8,972Aprogenex APG/1Q 0/NA# (1,491)/(709) (0.32)/(0.23) 902/130% 7,284 4,635Atrix Laboratories ATRX/1Q 432/-42% (1,426)/(872) (0.18)/(0.11) 1,617/20% NA 7,736Cantab Pharmaceuticals CNTBY/1Q 296/23% (1,159)/(1,151) (0.12)/(0.19) 1,445/20% 28,861 9,837Deprenyl Animal Health DAHI/1Q 16/-77% (658)/(437) (0.10)/(0.07) NA/NA 1,659 6,484ICN Pharmaceuticals ICN/1Q 17,202/3% (4,545)/1,063 (0.22)/0.06 1,700/65% 18,566 20,523IGEN IGEN/4Q 3,264/-7% (388)/438 (0.03)/0.04 2,527/136% 41,746 13,309Innovir Laboratories INVR/2Q 29/2800% (730)/(858) (0.24)/(4.14) 467/21% 4,000 3,046InterPharm Laboratories IPLLF/1Q 13,441/6% 3,708/3,039 0.13/0.17 NA/NA NA 6,242Ligand Pharmaceuticals LGNDA/1Q 2,343/-21% (6,926)/(3,575) (0.48)/(0.25) 36,794/154% 36,794 14,490Oncogene Science ONCS/2Q 4,131/8% (1,280)/(1,070) (0.07)/(0.05) 2,831/12% 21,244 16,332Paracelsian PRLN/2Q 21/NA# (445)/(535) (0.19)/(0.23) NA/NA NA 2,312SangStat Medical SANG/1Q 986/512% (807)/(1,305) (0.12)/(0.26) 1,035/60% 10,595 6,961Shaman Pharmaceuticals SHMN/1Q 520/2% (4,058)/(1,842) (0.31)/(0.24) 4,125/89% 53,291 12,967

# Reported 0 revenues in comparable 1993 quarter.

All Symbols except ICN Pharmaceuticals (NYSE) and Aprogenex(ASE) are NASDAQ

(c) 1997 American Health Consultants. All rights reserved.